The SCN9A Polyclonal Antibody (PACO01132) is a specialized research tool designed for studying the sodium voltage-gated channel alpha subunit 9 (SCN9A), a key player in pain sensation and nociceptive signaling. This rabbit-derived antibody is highly specific to human samples and has been rigorously validated for use in Western blot applications.SCN9A, also known as Nav1.7, is a voltage-gated sodium channel that is predominantly expressed in sensory neurons and plays a crucial role in transmitting pain signals. Dysregulation of SCN9A has been implicated in various pain disorders, making it a promising target for therapeutic interventions and drug development.
By targeting the SCN9A protein, researchers can gain valuable insights into the mechanisms underlying pain perception and develop novel strategies for managing chronic pain conditions. The SCN9A Polyclonal Antibody is an essential tool for studies in neuroscience, pain research, and drug discovery, offering reliable and specific detection of SCN9A in various cell types and tissues.
Antibody Name:
SCN9A Antibody
Antibody SKU:
PACO01132
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, WB, IHC
Recommended Dilutions:
WB:1:500-1:2000, IHC:1:100-1:300
Species Reactivity:
Human, Mouse, Rat
Immunogen:
synthesized peptide derived from the Internal region of human Na+ CP type IXalpha.
Form:
Liquid
Storage Buffer:
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Clonality:
Polyclonal
Isotype:
IgG
Conjugate:
Non-conjugated
Synonyms:
SCN9A; NENA; Sodium channel protein type 9 subunit alpha; Neuroendocrine sodium channel; hNE-Na; Peripheral sodium channel 1; PN1; Sodium channel protein type IX subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.7
